Central Drugs Standard Control Organization

From LIMSWiki
Revision as of 14:20, 12 March 2016 by Admin (talk | contribs) (Transcluded, per John)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
Central Drugs Standard Control Organisation
Organisation overview
TypeRegulatory body
HeadquartersNew Delhi, India
28°37′56″N 77°14′08″E / 28.632309°N 77.235531°E / 28.632309; 77.235531
Annual budget₹3,358 crore (US$400 million) Decrease (2021 - 2022) [1]
Minister responsible
Organisation executive
  • Rajeev Singh Raghuvanshi, Drugs Controller General of India
Parent departmentDirectorate General of Health Services, Ministry of Health and Family Welfare
Websitecdsco.gov.in and www.cdscoonline.gov.in

The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices. It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union. The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO).

Within the CDSCO, the Drug Controller General of India (DCGI) regulates pharmaceutical and medical devices and is positioning within the Ministry of Health and Family Welfare. The DCGI is advised by the Drug Technical Advisory Board (DTAB) and the Drug Consultative Committee (DCC). Divided into zonal offices, each one carries out pre-licensing and post-licensing inspections, post-market surveillance, and drug recalls (where necessary). Manufacturers who deal with the authority required to name an Authorized Indian Representative (AIR) to represent them in all dealings with the CDSCO in India.

Divisions

Central Drugs Standard Control Organization has 8 divisions:

  • BA/BE[2]
  • New Drugs[3]
  • Medical Device & Diagnostics[4]
  • DCC-DTAB[5]
  • Import & Registration[6]
  • Biological[7]
  • Cosmetics[8]
  • Clinical Trials[9]

See also

References

  1. ^ "Datasets - Open Budgets India".
  2. ^ "BA/BE". cdsco.gov.in. Retrieved 2020-12-29.
  3. ^ "New Drugs". cdsco.gov.in. Retrieved 2020-12-29.
  4. ^ "Medical device & diagnostics". cdsco.gov.in. Retrieved 2020-12-29.
  5. ^ "DTAB-DCC". cdsco.gov.in. Retrieved 2020-12-29.
  6. ^ "Imports & Registration". cdsco.gov.in. Retrieved 2020-12-29.
  7. ^ "biologicals". cdsco.gov.in. Retrieved 2020-12-29.
  8. ^ "cosmetics". cdsco.gov.in. Retrieved 2020-12-29.
  9. ^ "Committees". cdsco.gov.in. Retrieved 2020-12-29.

Notes

This article is a direct transclusion of the Wikipedia article and therefore may not meet the same editing standards as LIMSwiki.

Retrieved from "https://www.limswiki.org/index.php?title=Central_Drugs_Standard_Control_Organization&oldid=24685"